Codexis

Yahoo Finance • last month

Codexis to Participate in Cantor Global Healthcare Conference

REDWOOD CITY, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced the Company will attend... Full story

Yahoo Finance • 2 months ago

Curious about the stocks that are showing activity after the closing bell on Wednesday?

As the regular session of the US market concludes on Wednesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. [postmarket] TODAY'S AFTER HOURS GAINERS TICKER... Full story

Yahoo Finance • 2 months ago

Codexis Inc (NASDAQ:CDXS) Surpasses Q2 2025 Earnings Expectations with Strong Revenue and EPS Beat

Codexis Inc (NASDAQ:CDXS [https://www.chartmill.com/stock/quote/CDXS]) reported its second-quarter 2025 financial results, delivering revenue and earnings per share (EPS) figures that surpassed analyst expectations. The company's performan... Full story

Yahoo Finance • 2 months ago

Codexis Reports Second Quarter 2025 Financial Results

Announces revenue of $15.3M vs $14.1M analyst consensus estimate Six presentations featured ECO Synthesis® platform at 2025 TIDES USA annual meeting, including three from leading CDMO collaborators $27.3M raised via ATM facility and Inno... Full story

Yahoo Finance • 2 months ago

Here are the major earnings after the close Wednesday

Major earnings expected after the bell on Wednesday include: * Cisco Systems (CSCO [https://seekingalpha.com/symbol/CSCO]) * Coherent Corp. (COHR [https://seekingalpha.com/symbol/COHR]) * Vaxart (OTC:VXRT [https://seekingalpha.com/s... Full story

Yahoo Finance • 2 months ago

[Latest] Global AI in Synthetic Biology Market Size/Share Worth USD 192.95 Billion by 2034 at a 28.63% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global AI in Synthetic Biology Market size & share revenue was valued at approximately USD... Full story

Yahoo Finance • 2 months ago

S&P Futures Gain as Fed Rate-Cut Bets Firm

September S&P 500 E-Mini futures (ESU25 [https://www.barchart.com/futures/quotes/ESU25]) are trending up +0.24% this morning, extending yesterday’s gains as growing expectations for Federal Reserve interest rate cuts fueled risk-on sentime... Full story

Yahoo Finance • 4 months ago

Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA

Presentations by leading siRNA CDMOs, Bachem, Nitto Avecia, and ST Pharm, highlight performance and transferability of Codexis double-stranded RNA ligases Management to host conference call today at 8 am Eastern Time to discuss data REDW... Full story

Yahoo Finance • 4 months ago

Codexis to Participate in Jefferies Global Healthcare Conference

REDWOOD CITY, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the Company will attend the Jefferies G... Full story

Yahoo Finance • 5 months ago

Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting

Codexis to showcase data that demonstrate the scalability and reproducibility of its enzymatic siRNA manufacturing processes Three CDMO presentations to feature data on performance of Codexis double-stranded RNA ligases Management will h... Full story

Yahoo Finance • 6 months ago

Codexis Announces Byron Dorgan to Retire from Board of Directors

REDWOOD CITY, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced that Byron Dorgan will retire from th... Full story

Yahoo Finance • 7 months ago

Codexis Announces New Employment Inducement Grants

REDWOOD CITY, Calif., March 07, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the approval of equity grants to two... Full story

Yahoo Finance • 7 months ago

Codexis to Participate in TD Cowen 45th Annual Health Care Conference

REDWOOD CITY, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the Company will attend the TD Cowen 4... Full story

Yahoo Finance • 8 months ago

Codexis to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 27th

REDWOOD CITY, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced that it will report its financial resu... Full story

Yahoo Finance • 8 months ago

Codexis Appoints Arthur Levin, PhD, to Strategic Advisory Board

REDWOOD CITY, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of Arthur Levin, PhD,... Full story

Yahoo Finance • 2 years ago

Is It Time To Consider Buying Codexis, Inc. (NASDAQ:CDXS)?

Codexis, Inc. (NASDAQ:CDXS), might not be a large cap stock, but it received a lot of attention from a substantial price increase on the NASDAQGS over the last few months. As a stock with high coverage by analysts, you could assume any rec... Full story

Yahoo Finance • 2 years ago

Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase

Codexis, Inc.; Aldevron Deal creates strategic collaboration to enable more efficient RNA therapeutic development, providing a path to GMP-grade Codexis enzymes REDWOOD CITY, Calif. and FARGO, N.D., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Code... Full story

Yahoo Finance • 2 years ago

Codexis Announces Achievement of Gram-scale Synthesis with its ECO Synthesis™ Platform

Codexis, Inc. Milestone enables Codexis engineers to model the manufacturing process for RNAi therapeutics Company remains on track to initiate pre-commercial customer testing in 2024 REDWOOD CITY, Calif., Dec. 13, 2023 (GLOBE NEWSWIRE)... Full story

Yahoo Finance • 2 years ago

Codexis to Host Virtual KOL Event on its ECO Synthesis™ Platform and the Future of RNAi Therapeutics Manufacturing on December 8, 2023

REDWOOD CITY, Calif., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it will host a virtual key opinion leader (KOL) event focused on its Enzyme-Catalyzed Oligonucleo... Full story

Yahoo Finance • 2 years ago

Catherine Wood Adjusts Portfolio, Trims Tesla Stake by 1.33%

ARK Investment Management's Latest 13F Filing Highlights Key Stock Movements Renowned for her focus on disruptive innovation, Catherine Wood (Trades, Portfolio), the founder and CEO of ARK Investment Management, has made notable changes t... Full story